In clinical practice, a diagnosis of MCC is based on a histopathological report that shows positive immunostaining for CK20 and negative thyroid transcription factor-1 (TTF-1) expression [15,16]. This evidence concerns the gene KRT20 and Merkel cell skin cancer.